Back
NVU
Nanoveu Limited
๐ฆ๐บ ASX
๐จ COMMERCIAL SERVICES & SUPPLIES
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-8.66%
Annual Growth
5 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
4
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Nanoveu Ltd. is a technology company, which engages in developing a range of products for mobile phones and other digital displays. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-11-30. The firm specializes in protective films and coatings. Its products include Nanoshield, Nanoshield Marine, Nanoshield Solar, EyeFly3D, Customskins and EyeFyx. Nanoshield is a film that uses a patented polymer of cuprous embedded film to self-disinfect surfaces. Its Nanoshield antiviral protection product is available in a variety of shapes and forms, from mobile screen covers to mobile phone cases and as a poly vinyl chloride commercial film. Nanoshield Marine prevents the accumulation and growth of aquatic organisms such as algae, barnacles and mussels on the hulls of ships, boats and other structures that are submerged in water. Nanoshield Solar solves an issue for solar panels, being reduction of power output from panel surface debris. EyeFly3D is a film applied to digital displays that allows users to experience three-dimensional without the need for glasses on everyday mobile handheld devices.
๐ Performance
Price History
-81.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.04
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in NVU
4
๐ Total Capital Earnings
$2K
๐ Average investment frequency
20 weeks
๐ต Average investment amount
$1,738
โฐ Last time a customer invested in NVU
5 days
NVU investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
50%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
25%
35 - 90
75%
๐ Legal gender of investors
Female
Male
100%
Pearlers who invest in NVU also invest in...
Renascor Resources Ltd. engages in the exploration and evaluation of mineral property. The company is headquartered in Adelaide, South Australia. The company went IPO on 2010-12-15. The firm's projects include Siviour, Carnding, Marree, and Olary. The Carnding Project contains several near-surface, high-grade gold prospects (up to 16 g/t from previous drilling) in South Australia's Central Gawler Craton. At Carnding, the Company is targeting shallow, high-grade gold occurrences. Within the project area, the Company has identified multiple high priority gold targets based on shallow drilling. The Marree Project is a copper-prospective ground position within South Australia's Adelaide Fold Belt. Its exploration program is focused on identifying and drilling prospects for large tonnage Zambian Copper Belt-style, sedimentary copper deposits. The company holds 100% interest in the remaining Marree Project exploration licenses, EL 6170 and EL 6403.
๐ Performance (5Yr p.a)
128.89%
๐ Share price
$0.07 AUD
โ๏ธ MINING
Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. The company is headquartered in North Ryde, New South Wales. The company went IPO on 2001-01-24. The firm is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Companyโs clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.
๐ Performance (5Yr p.a)
-19.47%
๐ Share price
$0.00 AUD
๐งฌ BIOTECHNOLOGY
Arafura Rare Earths Ltd. engages in the exploration and development of mineral resource properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-11-05. The firm produces rare earth products from the Nolans Project. The Nolans Project consists of a mine, process plant, including beneficiation, extraction and separation plants, and related infrastructure to be constructed and located at the Nolans site, approximately 135 kilometers north of Alice Springs in Australia's Northern Territory. Its rare earth products are Neodymium-Praseodymium (NdPr) oxide, and Mixed middle-heavy rare earths (SEG/HRE) oxide. NdPr oxide is the Company's flagship product, which is used by magnet and magnet alloy customers. The Companyโs primary products from the Nolans project are rare earths, which are used in catalytic converters in automobiles, consumer electronics, energy efficiency lighting, optics, alloys, advanced ceramics and permanent magnets that enable e-mobility and renewable energy applications.
๐ Performance (5Yr p.a)
33.97%
๐ Share price
$0.17 AUD
โ๏ธ MINING
๐ HIGH PRICE GROWTH
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
20.93%
๐ Share price
$61.37 AUD
๐ HIGH PRICE GROWTH
๐ฐ HIGH DIVIDEND
๐บ๐ธ UNITED STATES
Avenira Ltd. engages in the business of mineral exploration. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-10-10. Its segments include Wonarah and Jundee South. Its projects include Wonarah Direct Shipping Ore (DSO) Phosphate Project and Jundee Project. The Wonarah DSO Project, which focuses on mining and selling high-grade phosphate ore from its Tier 1, 100% owned Wonarah Phosphate Mine. The project is designed as a simple open cut mining operation. The Wonarah Phosphate Project comprises six exploration licenses, two Mineral Leases and 1 access authority covering 1,413 square kilometers (km2). Jundee South Gold Project is located in the Yandal Region, Western Australia. The tenement package covers more than 1,586 square kilometers (km2) of the Yandal Greenstone Belt and includes tenements within five kilometers (km) of the Jundee (10Moz), Bronzewing (4Moz) and Darlot (3.5Moz) gold mines.
๐ Performance (5Yr p.a)
-6.24%
๐ Share price
$0.01 AUD
โ๏ธ MINING
Want more shares? Try these...